Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 
Tracking the Evolution of Cerebral Gadolinium-enhancing Lesions to Persistent T1 Black Holes in Multiple Sclerosis: Validation of a Semiautomated Pipeline
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
 
ID 4413085
Author(s) Andermatt, Simon; Papadopoulou, Athina; Radue, Ernst-Wilhelm; Sprenger, Till; Cattin, Philippe C.
Author(s) at UniBasel Cattin, Philippe Claude
Year 2017
Title Tracking the Evolution of Cerebral Gadolinium-enhancing Lesions to Persistent T1 Black Holes in Multiple Sclerosis: Validation of a Semiautomated Pipeline
Journal Journal of Neuroimaging
Volume 27
Number 5
Pages / Article-Number 469-475
Keywords Simon Andermatt
Mesh terms Brain, pathology; Gadolinium; Humans; Magnetic Resonance Imaging, methods; Multiple Sclerosis, pathology
Abstract BACKGROUND: Some gadolinium-enhancing multiple sclerosis (MS) lesions remain T1-hypointense over months ("persistent black holes, BHs") and represent areas of pronounced tissue loss. A reduced conversion of enhancing lesions to persistent BHs could suggest a favorable effect of a medication on tissue repair. However, the individual tracking of enhancing lesions can be very time-consuming in large clinical trials. PURPOSE: We created a semiautomated workflow for tracking the evolution of individual MS lesions, to calculate the proportion of enhancing lesions becoming persistent BHs at follow-up. METHODS: Our workflow automatically coregisters, compares, and detects overlaps between lesion masks at different time points. We tested the algorithm in a data set of Magnetic Resonance images (1.5 and 3T; spin-echo T1-sequences) from a phase 3 clinical trial (n = 1,272), in which all enhancing lesions and all BHs had been previously segmented at baseline and year 2. The algorithm analyzed the segmentation masks in a longitudinal fashion to determine which enhancing lesions at baseline turned into BHs at year 2. Images of 50 patients (192 enhancing lesions) were also reviewed by an experienced MRI rater, blinded to the algorithm results. RESULTS: In this MRI data set, there were no cases that could not be processed by the algorithm. At year 2, 417 lesions were classified as persistent BHs (417/1,613 = 25.9%). The agreement between the rater and the algorithm was > 98%. CONCLUSIONS: Due to the semiautomated procedure, this algorithm can be of great value in the analysis of large clinical trials, when a rater-based analysis would be time-consuming.
Publisher WILEY
ISSN/ISBN 1051-2284 ; 1552-6569
edoc-URL https://edoc.unibas.ch/63967/
Full Text on edoc No
Digital Object Identifier DOI 10.1111/jon.12439
PubMed ID http://www.ncbi.nlm.nih.gov/pubmed/28370651
ISI-Number WOS:000417436600006
Document type (ISI) Journal Article
 
   

MCSS v5.8 PRO. 0.359 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
29/03/2024